The Ca(2+)ATPase activities of highly purified human platelet membranes prepared by high-voltage free-flow electrophoresis have been analysed by using [gamma-P-32]ATP hydrolysis, recognition by antibodies and phosphoenzyme-complex formation. The Ca(2+)ATPase activity present in mixed membranes was found to be predominantly associated with intracellular membranes after subfractionation, with only a low level of activity associated with plasma membranes. The intracellular-membrane Ca(2+)ATPase activity was inhibited totally with thapsigargin (Tg), whereas the plasma-membrane Ca(2+)ATPase was not significantly affected, suggesting that the latter does not belong to the SERCA (sarco-endoplasmic-reticulum Ca(2+)ATPase) class. A monoclonal antibody, 5F10, raised to the red-cell membrane Ca(2+)ATPase [Cheng, Magocsi, Cooper, Penniston and Borke (1993) Cell Physiol. Biochem. 4, 31-43] recognized two bands at 135 and 150 kDa in mixed membranes and plasma membranes, and the corresponding bands in red-blood-cell membranes, confirming the Ca(2+)ATPase to be of the PMCA (plasma-membrane Ca(2+)ATPase) type. No recognition of any band was detected in intracellular membranes. Identification of the intracellular-membrane Ca(2+)ATPase activity was carried out with polyclonal antibodies with known specificity towards SERCA 2b (S.2b) and SERCA 3 (N89), and a monoclonal antibody, PL/IM 430, raised against platelet intracellular membranes. All of these antibodies recognized the 100 kDa Ca(2+)ATPase in mixed membranes and intracellular membranes, with little or no recognition of the activity in the plasma membranes. In some membrane preparations the antibody PL/IM 430 and antiserum N89 recognized similar degradation products, of 74, 70 and 40 kDa, in the intracellular-membrane fraction. The Ca(2+)ATPase recognized by PL/IM 430 was immunoprecipitated, and the immunoprecipitated protein was specifically recognized by the antiserum N89, but not by S.2b. Analysis of the phosphoenzyme-complex formation revealed potent phosphorylation of the 100 and 74 kDa peptides, both recognized by PL/IM 430 and N89. These studies report the presence of a PMCA in a purified plasmamembrane fraction from human platelets, and that the antibody PL/IM 430 recognizes the SERCA 3 Ca(2+)ATPase in intracellular membranes.
